Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Siontis KC, Santangeli P, Muser D, Marchlinski FE, Zeppenfeld K, Hoogendoorn JC, Narasimhan C, Sauer WH, Zipse MM, Kapa S, Vedantham V, Rosenthal DG, Robinson MR, Patton KK, Murgatroyd F, Chicos AB, Soejima K, Roukoz H, Sacher F, Bhan A, Appelbaum J, Dickfeld T, Mankad P, Ellenbogen KA, Kron J, Kim HM, Froehlich J, Eagle KA, Bogun FM, Crawford TC.
Siontis KC, et al. Among authors: ellenbogen ka.
JAMA Cardiol. 2022 Feb 1;7(2):175-183. doi: 10.1001/jamacardio.2021.4738.
JAMA Cardiol. 2022.
PMID: 34787643
Free PMC article.
The primary long-term outcome was the composite of VT recurrence, heart transplant (HT), or death. ...Preablation LV dysfunction and myocardial inflammation were associated with adverse long-term prognosis. These data support the role of catheter ablation in conjunc …
The primary long-term outcome was the composite of VT recurrence, heart transplant (HT), or death. ...Preablation LV dysfunction and …